Literature DB >> 32778915

Post-hepatectomy liver failure after hepatic resection for hepatocellular carcinoma: a single center experience.

Ahmed Shehta1, Ahmed Farouk2, Amgad Fouad2, Ahmed Aboelenin2, Ahmed Nabieh Elghawalby2, Rami Said2, Mohamed Elshobary2, Ayman El Nakeeb2.   

Abstract

PURPOSE: Post-hepatectomy liver failure (PHLF) is one of the most feared morbidities after liver resection (LR) for hepatocellular carcinoma (HCC). We aimed to investigate the incidence and predictors of PHLF after LR for HCC and its impact on survival outcomes.
METHODS: We reviewed the patients who underwent LR for HCC during the period between January 2010 and 2019.
RESULTS: Two hundred sixty-eight patients were included. Patients were divided into two groups according to the occurrence of PHLF, defined according to ISGLS. The non-PHLF group included 138 patients (51.5%), while the PHLF group included 130 patients (48.5%). Two hundred forty-six patients (91.8%) had hepatitis C virus. Major liver resections were more performed in the PHLF group (40 patients (30.8%) vs. 18 patients (13%), p = 0.001). Longer operation time (3 vs. 2.5 h, p = 0.001), more blood loss (1000 vs. 500 cc, p = 0.001), and transfusions (81 patients (62.3%) vs. 52 patients (37.7%), p = 0.001) occurred in PHLF group. The 1-, 3-, and 5-year Kaplan-Meier overall survival rates for the non-PHLF group were 93.9%, 79.5%, and 53.9% and 73.2%, 58.7%, and 52.4% for the PHLF group, respectively (log rank, p = 0.003). The 1-, 3-, and 5-year Kaplan-Meier disease-free survival rates for the non-PHLF group were 77.7%, 42.5%, and 29.4%, and 73.3%, 42.9%, and 25.3% for the PHLF group, respectively (log rank, p = 0.925). Preoperative albumin, bilirubin, INR, and liver cirrhosis were significant predictors of PHLF in the logistic regression analysis.
CONCLUSION: Egyptian patients with HCC experienced higher PHLF incidence after LR for HCC. PHLF significantly affected the long-term survival of those patients.

Entities:  

Keywords:  Hepatitis C virus; Hepatocellular carcinoma; Liver resection; Post-hepatectomy liver failure

Year:  2020        PMID: 32778915     DOI: 10.1007/s00423-020-01956-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  35 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan.

Authors:  S Arii; Y Yamaoka; S Futagawa; K Inoue; K Kobayashi; M Kojiro; M Makuuchi; Y Nakamura; K Okita; R Yamada
Journal:  Hepatology       Date:  2000-12       Impact factor: 17.425

Review 3.  Hepatocellular carcinoma.

Authors:  Hashem B El-Serag
Journal:  N Engl J Med       Date:  2011-09-22       Impact factor: 91.245

4.  Screening and Treatment Program to Eliminate Hepatitis C in Egypt.

Authors:  Imam Waked; Gamal Esmat; Aisha Elsharkawy; Magdy El-Serafy; Wael Abdel-Razek; Reham Ghalab; Galal Elshishiney; Aysam Salah; Soad Abdel Megid; Khaled Kabil; Manal H El-Sayed; Hany Dabbous; Yehia El Shazly; Mohamed Abo Sliman; Khalid Abou Hashem; Sayed Abdel Gawad; Nevine El Nahas; Ahmed El Sobky; Sahar El Sonbaty; Hamdy El Tabakh; Ehab Emad; Hany Gemeah; Amal Hashem; Mohamed Hassany; Naseif Hefnawy; Abdel N Hemida; Ayman Khadary; Kamal Labib; Faisal Mahmoud; Said Mamoun; Tamer Marei; Saad Mekky; Alsayeda Meshref; Alaa Othman; Omnia Ragab; Elhag Ramadan; Ahmed Rehan; Tarek Saad; Ramy Saeed; Mohamed Sharshar; Hesham Shawky; Mohamed Shawky; Wael Shehata; Hanaa Soror; Mohsen Taha; Mahmoud Talha; Adel Tealaab; Mohamed Zein; Alaa Hashish; Ahmed Cordie; Yasser Omar; Ehab Kamal; Islam Ammar; Mohamed AbdAlla; Wafaa El Akel; Wahid Doss; Hala Zaid
Journal:  N Engl J Med       Date:  2020-03-19       Impact factor: 91.245

5.  Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience.

Authors:  Ahmed Shehta; Ho-Seong Han; Yoo-Seok Yoon; Jai Young Cho; YoungRok Choi
Journal:  Surg Endosc       Date:  2015-06-20       Impact factor: 4.584

6.  Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma.

Authors:  Kenji Fukushima; Takumi Fukumoto; Kaori Kuramitsu; Masahiro Kido; Atsushi Takebe; Motofumi Tanaka; Tomoo Itoh; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2013-12-03       Impact factor: 3.452

7.  Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Authors:  Francis Y Yao; Nathan M Bass; Bev Nikolai; Timothy J Davern; Robert Kerlan; Victor Wu; Nancy L Ascher; John P Roberts
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

8.  Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis.

Authors:  Yuichiro Kawano; Atsushi Sasaki; Seiichiro Kai; Yuichi Endo; Kentaro Iwaki; Hiroki Uchida; Kohei Shibata; Masayuki Ohta; Seigo Kitano
Journal:  Ann Surg Oncol       Date:  2008-03-27       Impact factor: 5.344

9.  Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.

Authors:  William R Jarnagin; Mithat Gonen; Yuman Fong; Ronald P DeMatteo; Leah Ben-Porat; Sarah Little; Carlos Corvera; Sharon Weber; Leslie H Blumgart
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

10.  Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma.

Authors:  K S Chok; K K Ng; R T Poon; C M Lo; S T Fan
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

View more
  6 in total

1.  Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma.

Authors:  Jianchen Luo; Liangliang Xu; Lian Li; Jingfu Zhang; Ming Zhang; Mingqing Xu
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 2.  Prognostic role of preoperative albumin-bilirubin score in posthepatectomy liver failure and mortality: a systematic review and meta-analysis.

Authors:  Shuai Zhou; Shuangchi Liu; Huichun Liu; Qing Pang; Zheng Lu
Journal:  Updates Surg       Date:  2021-05-19

Review 3.  Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures.

Authors:  Reem Ezzat; Mohamed Eltabbakh; Mohamed El Kassas
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

4.  A Clinical-Radiomic Model for Predicting Indocyanine Green Retention Rate at 15 Min in Patients With Hepatocellular Carcinoma.

Authors:  Ji Wu; Feng Xie; Hao Ji; Yiyang Zhang; Yi Luo; Lei Xia; Tianfei Lu; Kang He; Meng Sha; Zhigang Zheng; Junekong Yong; Xinming Li; Di Zhao; Yuting Yang; Qiang Xia; Feng Xue
Journal:  Front Surg       Date:  2022-03-24

5.  Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy.

Authors:  Ruth Baumgartner; Stefan Gilg; Bergthor Björnsson; Kristina Hasselgren; Poya Ghorbani; Christina Sauter; Per Stål; Per Sandstöm; Ernesto Sparrelid; Jennie Engstrand
Journal:  BJS Open       Date:  2022-07-07

Review 6.  Bile Leakage After Hepatic Resection for Hepatocellular Carcinoma: Does It Impact the Short- and Long-term Outcomes?

Authors:  Ahmed Shehta; Ahmed Farouk; Rami Said; Ayman El Nakeeb; Ahmed Aboelenin; Mohamed Elshobary; Amgad Fouad; Ahmed Nabieh Elghawalby
Journal:  J Gastrointest Surg       Date:  2022-08-24       Impact factor: 3.267

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.